Olivia Rodrigo's "drop dead," the lead single from her forthcoming third album, debuted at No. 1 on Billboard's Hot 100 chart published Saturday morning, the first time in the chart's sixty-eight-year history that a single artist's first three album cycles have each opened with a No. 1 lead single. [1] The song dethroned Ella Langley's "Choosin' Texas," which slid to No. 2 on the same week's report. The Cure's 1992 single "Friday I'm In Love," interpolated in the second verse, returned to the Hot 100 at No. 47 on the streaming bump. [2]

The mechanism behind the historic line is itself a story. Rodrigo's label released six versions of "drop dead" — original, acoustic, sped-up, slowed-down, instrumental, and a cappella — over a fifteen-day promotional window. Under Billboard's chart rule, those six versions count as a single chart entry; the streams aggregate. The May 1 paper's account of the FCC's eight-station ABC license cliff was a story about chart-the-broadcaster; Saturday's pop chart is a story about chart-the-streamer, and the methodology is again the artifact.

Rodrigo's two prior album-cycle lead singles — "drivers license" in January 2021 and "vampire" in June 2023 — also debuted at No. 1, each on the strength of a similar variants-and-deluxe stack. Billboard's data team confirmed Saturday that no other artist had achieved three-for-three on lead-single debuts; Taylor Swift, Ariana Grande, and Drake have each gone two-for-three. [3] The chart's comparative trick is that Rodrigo has only released two albums; "drop dead" is the third album cycle's first ticket. The historic claim, in other words, is structurally about the cycle, not the discography.

The Cure's bump is the catalog-economics line the paper has been tracing through Avex's $100M fund and Lionsgate's Jackson-estate equity stake. Universal Music Publishing, which controls "Friday I'm In Love" with co-writer Robert Smith, will collect interpolation royalties on every "drop dead" stream. At the song's current pace — Luminate logged 92.4 million U.S. streams in its opening week — the Smith-side royalty share over a single chart cycle will run into seven figures. [4] Smith posted a one-line acknowledgement Friday on X welcoming the use; the implicit endorsement is part of the price.

Billboard's Hot 100 moved its variant-aggregation rule into effect in March 2024 in response to Drake's "Slime You Out" and Taylor Swift's "Cruel Summer," which had each used multi-version releases to dominate weekly streaming. The rule's stated aim was to make the chart reflect a song, not a release strategy. The rule has not slowed the strategy; it has formalized it. Saturday's report is the cleanest test yet: a single song with six addressable versions, one chart line, and a No. 1 debut.

The label arithmetic is more interesting than the chart arithmetic. Geffen Records, which signed Rodrigo in 2020, will recover the entire promotional cost of the album cycle off "drop dead" alone — Geffen's earned share of streaming revenue at the song's current pace clears $14M in the opening month, against an estimated marketing spend below $5M for the lead single. The album, "GUTS RETURNS," is announced for release June 12. The lead single, in chart terms, is now the album's economic floor. [5]

For Robert Smith, who has spent the past two decades publicly resisting catalog sales — he turned down a reported nine-figure offer from Hipgnosis in 2023 and a separate Concord approach in 2024 — the interpolation income is the closest the Cure catalog has come to selling without selling. Smith owns 100% of his publishing; the catalog-acquisition market has been waiting on him for a generation. The "drop dead" interpolation re-prices that wait. A buyer evaluating the Cure's publishing on a 2026 multiple now has to model Gen Z interpolation as a recurring revenue line, not a one-off. [6]

Rodrigo's announcement Friday that the album's deluxe edition will arrive in late June with a "Friday I'm In Love" full cover by Smith and Rodrigo together is the next mechanism. A duet recording of an existing copyright pulls a different royalty stack — master-side fees, performance bonuses, sync potential — that does not count toward the "drop dead" chart entry but does count toward the Cure's catalog yield. The single chart line, in other words, is the front door. The catalog ledger is the back office. [7]

-- CAMILLE BEAUMONT, Los Angeles